Thromboangiitis Obliterans Latest Advances

Exploration of effective substances and mechanisms of Corydalis Herba for treating thromboangiitis obliterans based on UHPLC-Q-TOF-MS/MS, network pharmacology, and molecular docking analyses

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

Published: August 02, 2026

Patient testimonial: living with Buerger's disease

Journal: Soins; la revue de reference infirmiere

Published: July 29, 2026

Lumbar Sympathetic Radiofrequency Ablation for Peripheral Arterial Disease: A Short-Term, Self-Controlled, Retrospective Pilot Study of 16 Patients.

Journal: Journal of pain research

Published: June 19, 2026

Thromboangiitis Obliterans of the Colon: An Unusual Manifestation of Buerger's Disease.

Journal: The Israel Medical Association journal : IMAJ

Published: June 16, 2026

Corrigendum to "Integrated metabolomics and network pharmacology study on Si-miao-yong-an Decoction in regulating sphingolipid metabolism and improving vascular injury on thromboangiitis obliterans" [J. Ethnopharmacol. 357 (2026) 120868].

Journal: Journal of ethnopharmacology

Published: June 15, 2026

Segment-Specific Distal Crural Artery Intima-Media Thickness and Systemic Inflammatory Markers in Thromboangiitis Obliterans.

Journal: Journal of clinical ultrasound : JCU

Published: May 30, 2026

Efficacy of the Tibial Transverse Bone Transport Technique in the Management of Thromboangiitis Obliterans: A Systematic Review.

Journal: Journal of clinical medicine

Published: May 12, 2026

Outcomes of endovascular revascularization of upper limb thromboangiitis obliterans via palmar arch angioplasty.

Journal: International angiology : a journal of the International Union of Angiology

Published: May 12, 2026

Long-term outcomes of endovascular therapy in Buerger disease with critical limb ischemia: a retrospective observational study.

Journal: International angiology : a journal of the International Union of Angiology

Published: April 22, 2026

Vaping and vascular health: emerging risks for Raynaud's, chilblains and Buerger's disease.

Journal: Rheumatology (Oxford, England)

Published: March 27, 2026

Distal brachial-radial artery bypass with periarterial sympathectomy in Buerger disease: a case report.

Journal: Journal of surgical case reports

Published: March 23, 2026

Ischemic toe ulcer secondary to Buerger's disease managed with low-pressure negative pressure wound therapy and a moisture-preserving interface: a case report.

Journal: International journal of surgery case reports

Published: March 08, 2026

Thromboangiitis Obliterans Latest Advances

Find the Latest Research About Thromboangiitis Obliterans

Exploration of effective substances and mechanisms of Corydalis Herba for treating thromboangiitis obliterans based on UHPLC-Q-TOF-MS/MS, network pharmacology, and molecular docking analyses

Exploration of effective substances and mechanisms of Corydalis Herba for treating thromboangiitis obliterans based on UHPLC-Q-TOF-MS/MS, network pharmacology, and molecular docking analyses

Patient testimonial: living with Buerger's disease

Patient testimonial: living with Buerger's disease

Lumbar Sympathetic Radiofrequency Ablation for Peripheral Arterial Disease: A Short-Term, Self-Controlled, Retrospective Pilot Study of 16 Patients.

Lumbar Sympathetic Radiofrequency Ablation for Peripheral Arterial Disease: A Short-Term, Self-Controlled, Retrospective Pilot Study of 16 Patients.

Thromboangiitis Obliterans of the Colon: An Unusual Manifestation of Buerger's Disease.

Thromboangiitis Obliterans of the Colon: An Unusual Manifestation of Buerger's Disease.

Corrigendum to "Integrated metabolomics and network pharmacology study on Si-miao-yong-an Decoction in regulating sphingolipid metabolism and improving vascular injury on thromboangiitis obliterans" [J. Ethnopharmacol. 357 (2026) 120868].

Corrigendum to "Integrated metabolomics and network pharmacology study on Si-miao-yong-an Decoction in regulating sphingolipid metabolism and improving vascular injury on thromboangiitis obliterans" [J. Ethnopharmacol. 357 (2026) 120868].

Segment-Specific Distal Crural Artery Intima-Media Thickness and Systemic Inflammatory Markers in Thromboangiitis Obliterans.

Segment-Specific Distal Crural Artery Intima-Media Thickness and Systemic Inflammatory Markers in Thromboangiitis Obliterans.

Efficacy of the Tibial Transverse Bone Transport Technique in the Management of Thromboangiitis Obliterans: A Systematic Review.

Efficacy of the Tibial Transverse Bone Transport Technique in the Management of Thromboangiitis Obliterans: A Systematic Review.

Outcomes of endovascular revascularization of upper limb thromboangiitis obliterans via palmar arch angioplasty.

Outcomes of endovascular revascularization of upper limb thromboangiitis obliterans via palmar arch angioplasty.

Long-term outcomes of endovascular therapy in Buerger disease with critical limb ischemia: a retrospective observational study.

Long-term outcomes of endovascular therapy in Buerger disease with critical limb ischemia: a retrospective observational study.

Vaping and vascular health: emerging risks for Raynaud's, chilblains and Buerger's disease.

Vaping and vascular health: emerging risks for Raynaud's, chilblains and Buerger's disease.

Distal brachial-radial artery bypass with periarterial sympathectomy in Buerger disease: a case report.

Distal brachial-radial artery bypass with periarterial sympathectomy in Buerger disease: a case report.

Ischemic toe ulcer secondary to Buerger's disease managed with low-pressure negative pressure wound therapy and a moisture-preserving interface: a case report.

Ischemic toe ulcer secondary to Buerger's disease managed with low-pressure negative pressure wound therapy and a moisture-preserving interface: a case report.